Thymic involution, a co-morbidity factor in amyotrophic lateral sclerosis

Journal of Cellular and Molecular Medicine

Volumn 14, Issue 10, 2010, Pages 2470-2482

  Seksenyan, Akop ^a   Ron Harel, Noga ^b   Azoulay, David ^a   Cahalon, Liora ^b   Cardon, Michal ^b   Rogeri, Patricia ^a   Ko, Minhee K ^a   Weil, Miguel ^c   Bulvik, Shlomo ^d   Rechavi, Gideon ^e   Amariglio, Ninette ^e   Konen, Eli ^e   Koronyo Hamaoui, Maya ^a   Somech, Raz ^e   Schwartz, Michal ^a,b  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

^d LANIADO HOSPITAL   (Israel)

^e SHEBA MEDICAL CENTER   (Israel)

Author keywords

Amyotrophic lateral sclerosis; Immune deficiency; Immunomodulation; Neurodegeneration; Neuroprotection; Protective autoimmunity; T cells; Thymus involution

Indexed keywords

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL; ARTICLE; CD4+ T LYMPHOCYTE; DISEASE MODEL; FEMALE; GENE EXPRESSION PROFILING; GENE REARRANGEMENT; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; THYMUS; TRANSGENIC MOUSE;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION PROFILING; GENE REARRANGEMENT, T-LYMPHOCYTE; HUMANS; MALE; MICE; MICE, TRANSGENIC; MIDDLE AGED; THYMUS GLAND;

ANIMALIA; MUS;

EID: 77958530786     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2009.00863.x     Document Type: Article

References (84)

1. Lee JR, Annegers JF, Appel SH. Prognosis of amyotrophic lateral sclerosis and the effect of referral selection. J Neurol Sci. 1995; 132: 207-15.
2. Rosen DR. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993; 362: 59-62.
3. Boillee S, Yamanaka K, Lobsiger CS et al Onset and progression in inherited ALS determined by motor neurons and microglia. Science. 2006; 312: 1389-92.
4. Clement AM, Nguyen MD, Roberts EA et al Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science. 2003; 302: 113-7.
5. Gowing G, Philips T, Van Wijmeersch B et al Ablation of proliferating microglia does not affect motor neuron degeneration in amyotrophic lateral sclerosis caused by mutant superoxide dismutase. J Neurosci. 2008; 28: 10234-44.
6. Beers DR, Henkel JS, Xiao Q et al Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis. Proc Natl Acad Sci USA. 2006; 103: 16021-6.
7. Hauben E, Butovsky O, Nevo U et al Passive or active immunization with myelin basic protein promotes recovery from spinal cord contusion. J Neurosci. 2000; 20: 6421-30.
8. Moalem G, Leibowitz-Amit R, Yoles E et al Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat Med. 1999; 5: 49-55.
9. Rolls A, Shechter R, London A et al Two faces of chondroitin sulfate proteoglycan in spinal cord repair: a role in microglia/macrophage activation. PLoS Med. 2008; 5: e171.
10. Ron-Harel N, Segev Y, Lewitus GM et al Age dependent spatial memory loss can be restored by immune activation. Rejuvenation Research. 2008; 11: 903-13.
11. Ziv Y, Avidan H, Pluchino S et al Synergy between immune cells and adult neural stem/progenitor cells promotes functional recovery from spinal cord injury. Proc Natl Acad Sci USA. 2006; 103: 13174-9.
12. Ziv Y, Ron N, Butovsky O et al Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood. Nat Neurosci. 2006; 9: 268-75.
13. Douek DC, McFarland RD, Keiser PH et al Changes in thymic function with age and during the treatment of HIV infection. Nature. 1998; 396: 690-5.
14. Kipnis J, Cohen H, Cardon M et al T cell deficiency leads to cognitive dysfunction: implications for therapeutic vaccination for schizophrenia and other psychiatric conditions. Proc Natl Acad Sci USA. 2004; 101: 8180-5.
15. Kipnis J, Yoles E, Schori H et al Neuronal survival after CNS insult is determined by a genetically encoded autoimmune response. J Neurosci. 2001; 21: 4564-71.
16. Yoles E, Hauben E, Palgi O et al Protective autoimmunity is a physiological response to CNS trauma. J Neurosci. 2001; 21: 3740-8.
17. Hauben E, Agranov E, Gothilf A et al Posttraumatic therapeutic vaccination with modified myelin self-antigen prevents complete paralysis while avoiding autoimmune disease. J Clin Invest. 2001; 108: 591-9.
18. Schori H, Kipnis J, Yoles E et al Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: implications for glaucoma. Proc Natl Acad Sci USA. 2001; 98: 3398-403.
19. Cohen H, Ziv Y, Cardon M et al Maladaptation to mental stress mitigated by the adaptive immune system via depletion of naturally occurring regulatory CD4+CD25+ cells. J Neurobiol. 2006; 66: 552-63.
20. Beers DR, Henkel JS, Zhao W et al CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS. Proc Natl Acad Sci USA. 2008; 105: 15558-63.
21. Frenkel D, Maron R, Burt DS et al Nasal vaccination with a proteosome-based adjuvant and glatiramer acetate clears beta-amyloid in a mouse model of Alzheimer disease. J Clin Invest. 2005; 115: 2423-33.
22. Butovsky O, Koronyo-Hamaoui M, Kunis G et al Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1. Proc Natl Acad Sci USA. 2006; 103: 11784-9.
23. Benner EJ, Mosley RL, Destache CJ et al Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease. Proc Natl Acad Sci USA. 2004; 101: 9435-40.
24. Banerjee R, Mosley RL, Reynolds AD et al Adaptive immune neuroprotection in G93A-SOD1 amyotrophic lateral sclerosis mice. PLoS ONE. 2008; 3: e2740.
25. Chiu IM, Chen A, Zheng Y et al T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS. Proc Natl Acad Sci USA. 2008; 105: 17913-8.
26. Angelov DN, Waibel S, Guntinas-Lichius O et al Therapeutic vaccine for acute and chronic motor neuron diseases: implications for amyotrophic lateral sclerosis. Proc Natl Acad Sci USA. 2003; 100: 4790-5.
27. Schwartz M, Ziv Y. Immunity to self and self-maintenance: what can tumor immunology teach us about ALS and Alzheimer's disease? Trends Pharmacol Sci. 2008; 29: 287-93.
28. Andaloussi AE, Han Y, Lesniak MS. Progression of intracranial glioma disrupts thymic homeostasis and induces T-cell apoptosis in vivo. Cancer Immunol Immunother. 2008; 57: 1807-16.
29. Paz-Miguel JE, Flores R, Sanchez-Velasco P et al Reactive oxygen intermediates during programmed cell death induced in the thymus of the Ts(1716)65Dn mouse, a murine model for human Down's syndrome. J Immunol. 1999; 163: 5399-410.
30. Prass K, Meisel C, Hoflich C et al Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med. 2003; 198: 725-36.
31. Schwartz M, Ziv Y. Immunity to self and self-maintenance: a unified theory of brain pathologies. Trends Immunol. 2008; 29: 211-9.
32. Dik WA, Pike-Overzet K, Weerkamp F et al New insights on human T cell development by quantitative T cell receptor gene rearrangement studies and gene expression profiling. J Exp Med. 2005; 201: 1715-23.
33. Van Dongen JJ, Langerak AW, Bruggemann M et al Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia. 2003; 17: 2257-317.
34. Takahama Y. Journey through the thymus: stromal guides for T-cell development and selection. Nat Rev Immunol. 2006; 6: 127-35.
35. Pearse G. Normal structure, function and histology of the thymus. Toxicol Pathol. 2006; 34: 504-14.
36. Kim G, Kohyama K, Tanuma N et al Persistent expression of experimental autoimmune encephalomyelitis (EAE)-specific Vbeta8.2 TCR spectratype in the central nervous system of rats with chronic relapsing EAE. J Immunol. 1998; 161: 6993-8.
37. Linton PJ, Dorshkind K. Age-related changes in lymphocyte development and function. Nat Immunol. 2004; 5: 133-9.
38. Taub DD, Longo DL. Insights into thymic aging and regeneration. Immunol Rev. 2005; 205: 72-93.
39. Hazenberg MD, Verschuren MC, Hamann D et al T cell receptor excision circles as markers for recent thymic emigrants: basic aspects, technical approach, and guidelines for interpretation. J Mol Med. 2001; 79: 631-40.
40. Voustianiouk A, Seidel G, Panchal J et al ALSFRS and appel ALS scores: discordance with disease progression. Muscle Nerve. 2008; 37: 668-72.
41. Asnafi V, Beldjord K, Boulanger E et al Analysis of TCR, pT alpha, and RAG-1 in T-acute lymphoblastic leukemias improves understanding of early human T-lymphoid lineage commitment. Blood. 2003; 101: 2693-703.
42. Hollander GA, Wang B, Nichogiannopoulou A et al Developmental control point in induction of thymic cortex regulated by a subpopulation of prothymocytes. Nature. 1995; 373: 350-3.
43. Shores EW, Van Ewijk W, Singer A. Disorganization and restoration of thymic medullary epithelial cells in T cell receptor-negative scid mice: evidence that receptor-bearing lymphocytes influence maturation of the thymic microenvironment. Eur J Immunol. 1991; 21: 1657-61.
44. Nikolich-Zugich J, Slifka MK, Messaoudi I. The many important facets of T-cell repertoire diversity. Nat Rev Immunol. 2004; 4: 123-32.
45. Van Krieken JH, Langerak AW, Macintyre EA et al Improved reliability of lymphoma diagnostics via PCR-based clonality testing: report of the BIOMED-2 Concerted Action BHM4-CT98-3936. Leukemia. 2007; 21: 201-6.
46. Theodorou I, Raphael M, Bigorgne C et al Recombination pattern of the TCR gamma locus in human peripheral T-cell lymphomas. J Pathol. 1994; 174: 233-42.
47. Ponti R, Quaglino P, Novelli M et al T-cell receptor gamma gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides/Sezary syndrome) and benign inflammatory disease: correlation with clinical, histological and immunophenotypical findings. Br J Dermatol. 2005; 153: 565-73.
48. Ponti R, Fierro MT, Quaglino P et al TCRgamma-chain gene rearrangement by PCR-based GeneScan: diagnostic accuracy improvement and clonal heterogeneity analysis in multiple cutaneous T-cell lymphoma samples. J Invest Dermatol. 2008; 128: 1030-8.
49. Koch AE. Review: angiogenesis: implications for rheumatoid arthritis. Arthritis Rheum. 1998; 41: 951-62.
50. Greenfield EA, Nguyen KA, Kuchroo VK. CD28/B7 costimulation: a review. Crit Rev Immunol. 1998; 18: 389-418.
51. Nakanishi K, Yoshimoto T, Tsutsui H et al Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol. 2001; 19: 423-74.
52. Butovsky O, Ziv Y, Schwartz A et al Microglia activated by IL-4 or IFN-gamma differentially induce neurogenesis and oligodendrogenesis from adult stem/progenitor cells. Mol Cell Neurosci. 2006; 31: 149-60.
53. Rolls A, Shechter R, London A et al Toll-like receptors modulate adult hippocampal neurogenesis. Nat Cell Biol. 2007; 9: 1081-8.
54. Shaked I, Tchoresh D, Gersner R et al Protective autoimmunity: interferon-gamma enables microglia to remove glutamate without evoking inflammatory mediators. J Neurochem. 2005; 92: 997-1009.
55. Butovsky O, Talpalar AE, Ben-Yaakov K et al Activation of microglia by aggregated beta-amyloid or lipopolysaccharide impairs MHC-II expression and renders them cytotoxic whereas IFN-gamma and IL-4 render them protective. Mol Cell Neurosci. 2005; 29: 381-93.
56. Kipnis J, Yoles E, Porat Z et al T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies. Proc Natl Acad Sci USA. 2000; 97: 7446-51.
57. Butovsky O, Bukshpan S, Kunis G et al Microglia can be induced by IFN-gamma or IL-4 to express neural or dendritic-like markers. Mol Cell Neurosci. 2007; 35: 490-500.
58. Kanekura K, Suzuki H, Aiso S et al ER stress and unfolded protein response in amyotrophic lateral sclerosis. Mol Neurobiol. 2009; 39: 81-9.
59. Staal FJ, Luis TC, Tiemessen MM. WNT signalling in the immune system: WNT is spreading its wings. Nat Rev Immunol. 2008; 8: 581-93.
60. Graves MC, Fiala M, Dinglasan LA et al Inflammation in amyotrophic lateral sclerosis spinal cord and brain is mediated by activated macrophages, mast cells and T cells. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004; 5: 213-9.
61. Weydt P, Weiss MD, Moller T et al Neuro-inflammation as a therapeutic target in amyotrophic lateral sclerosis. Curr Opin Investig Drugs. 2002; 3: 1720-4.
62. Butovsky O, Kunis G, Koronyo-Hamaoui M et al Selective ablation of bone marrow-derived dendritic cells increases amyloid plaques in a mouse Alzheimer's disease model. Eur J Neurosci. 2007; 26: 413-6.
63. Shechter R, London A, Varol C et al Essential role for myeloid derived cells in the recovery from spinal cord injury. Neuroscience 2008. Washington DC: The Society for Neuroscience's 38th Annual Meeting; Plos Medicine. 2009; 6: e1000113.
64. Rossignol S, Schwab M, Schwartz M et al Spinal cord injury: time to move? J Neurosci. 2007; 27: 11782-92.
65. Rapalino O, Lazarov-Spiegler O, Agranov E et al Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats. Nat Med. 1998; 4: 814-21.
66. Schwartz M, Yoles E. Immune-based therapy for spinal cord repair: autologous macrophages and beyond. J Neurotrauma. 2006; 23: 360-70.
67. Butovsky O, Landa G, Kunis G et al Induction and blockage of oligodendrogenesis by differently activated microglia in an animal model of multiple sclerosis. J Clin Invest. 2006; 116: 905-15.
68. Zhao W, Xie W, Xiao Q et al Protective effects of an anti-inflammatory cytokine, interleukin-4, on motoneuron toxicity induced by activated microglia. J Neurochem. 2006; 99: 1176-87.
69. Mitchell RM, Freeman WM, Randazzo WT et al A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis. Neurology. 2009; 72: 14-9.
70. Ford L, Rowe D. Interleukin-12 and interferon-gamma are not detectable in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004; 5: 118-20.
71. Gordon PH, Moore DH, Miller RG et al Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial. Lancet Neurol. 2007; 6: 1045-53.
72. Bukshpan S, Kunis G, Schwartz M. Daily injection of glatiramer acetate is risky in a mouse model of ALS: different requirements for multiple sclerosis versus other neurodegenerative diseases. Biodrug. 2008; 22: 293-9.
73. Aharoni R, Teitelbaum D, Arnon R. T suppressor hybridomas and interleukin-2-dependent lines induced by copolymer 1 or by spinal cord homogenate down-regulate experimental allergic encephalomyelitis. Eur J Immunol. 1993; 23: 17-25.
74. Sprent J, Tough DF. Lymphocyte life-span and memory. Science. 1994; 265: 1395-400.
75. Zhang R, Miller RG, Gascon R et al Circulating endotoxin and systemic immune activation in sporadic amyotrophic lateral sclerosis (sALS). J Neuroimmunol. 2009; 206: 121-4.
76. McCormick AL, Brown RH Jr, Cudkowicz ME et al Quantification of reverse transcriptase in ALS and elimination of a novel retroviral candidate. Neurology. 2008; 70: 278-83.
77. Steele AJ, Al-Chalabi A, Ferrante K et al Detection of serum reverse transcriptase activity in patients with ALS and unaffected blood relatives. Neurology. 2005; 64: 454-8.
78. Nicolson GL, Nasralla MY, Haier J et al High frequency of systemic mycoplasmal infections in Gulf War veterans and civilians with amyotrophic lateral sclerosis (ALS). J Clin Neurosci. 2002; 9: 525-9.
79. Verma A, Berger JR. ALS syndrome in patients with HIV-1 infection. J Neurol Sci. 2006; 240: 59-64.
80. Prelog M, Schwarzenbrunner N, Sailer-Hock M et al Premature aging of the immune system in children with juvenile idiopathic arthritis. Arthritis Rheum. 2008; 58: 2153-62.
81. Yamanaka K, Yawalkar N, Jones DA et al Decreased T-cell receptor excision circles in cutaneous T-cell lymphoma. Clin Cancer Res. 2005; 11: 5748-55.
82. Stulnig T, Maczek C, Bock G et al Reference intervals for human peripheral blood lymphocyte subpopulations from 'healthy' young and aged subjects. Int Arch Allergy Immunol. 1995; 108: 205-10.
83. Hazenberg MD, Otto SA, Cohen Stuart JW et al Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of the naive T cell population in HIV-1 infection. Nat Med. 2000; 6: 1036-42.
84. Clark DR, De Boer RJ, Wolthers KC et al T cell dynamics in HIV-1 infection. Adv Immunol. 1999; 73: 301-27.